Browsing Tag
Diabetes management
21 posts
Medtronic’s MiniMed 780G System sets new standards in diabetes management
Medtronic plc (NYSE: MDT), a global frontrunner in medical technology, has recently unveiled compelling new clinical and real-world…
March 9, 2024
The comprehensive health benefits of Turmeric: A deep dive
Turmeric, often hailed as the “Queen of Spices,” holds a revered place not just in culinary traditions worldwide…
March 9, 2024
SkinBioTherapeutics partners with Umesh Modi Group for Dermatonics launch in AMEA
SkinBioTherapeutics plc (AIM: SBTX), a leading life science company focused on skin health, has announced a strategic partnership…
February 21, 2024
Pterocarpus Marsupium Medicinal Uses: A comprehensive guide
Understanding the significance and benefits of traditional medicinal plants is essential in today’s health-conscious world. One such revered…
August 19, 2023
Dr. Reddy’s Laboratories debuts generic version of KOMBIGLYZE XR in US
In a significant development for diabetes treatment in the U.S., Dr. Reddy’s Laboratories has unveiled its Saxagliptin and…
August 13, 2023
Revolutionizing diabetes care: Dexcom G7 CGM System gets Health Canada nod
Dexcom, a notable player in real-time continuous glucose monitoring (rtCGM) globally, confirmed today that Health Canada has given…
July 4, 2023
Lilly to transform chronic disease management with Sigilon Therapeutics acquisition
Pharmaceutical giant Eli Lilly and Company (Lilly) has announced its definitive agreement to acquire Nasdaq-listed biopharma innovator Sigilon…
June 30, 2023
Medtronic to acquire South Korean medical device company EOFlow
Ireland-based healthcare technology company Medtronic has announced an agreement to acquire EOFlow, a South Korean medical device company,…
May 29, 2023
Medtronic secures $337m from Blackstone to develop diabetes technologies
Irish medical device company Medtronic has secured a $337 million product investment from Blackstone Life Sciences for advancing new,…
June 14, 2020
Xeris Pharmaceuticals begins Phase 2 trial for glucagon in Type 1 diabetes patients
Xeris Pharmaceuticals, a specialty pharmaceutical company based in Chicago, has announced the commencement of dosing in its phase…
March 31, 2019